A NEWCASTLE-led research team, led by Professor Matt Dun, has secured an $18.7M Australian Government grant to develop next-generation therapies for high grade gliomas (HGG), the deadliest brain cancers. Backed by global experts, the team is creating brain-penetrant drugs to overcome the blood-brain barrier and improve survival when combined with radiotherapy. With clinical trials targeted within five years, the research offers new hope for patients and families facing DIPG and glioblastoma, cancers that currently have no effective treatment.
01October2025